Epizyme (EPZM) PT Lowered to $10 at Morgan Stanley
Tweet
Share
E-mailGet Alerts EPZM Hot Sheet
Price: $1.47 --0%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on Epizyme (NASDAQ: EPZM) to $10.00 (from $11.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- The Lovesac Co. (LOVE) PT Lowered to $18 at DA Davidson as Guidance Lowered
- Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
